They found that ANF treatment indeed reduced the expression of Ahr and the downstream molecules Cyp1a1 and Tnf-α, leading to reduced oxidative stress, insulin resistance, and attenuation of NAFLD [59]. Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.